speb/financial-data huggingface dataset:
Financial ratios for ALLIX.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.56818181818182
Shares outstanding: 6745610
Market cap (USD): 239929082.95454547
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALLIX.PA — annual report dated 2022-12-31
Total revenue: 26786170.21276596
Gross profit: 5157446.808510639
Operating income: -7520212.765957448
Net income: -6385106.382978723
Capital expenditures: 5920212.765957447
Operating cash flow: -2435106.3829787234
Depreciation & amortization: 4482978.723404256
Net tangible assets: -398936.170212766
Owner earnings: -7822340.425531914
Buffett classification: The Gruesome
Stock price: 12.553191489361703
Shares outstanding: 6745610
Book value: 18621276.595744677
P/B ratio: 4.547429044789764
Market cap (USD): 84678934.0425532
Debt to equity: 0.111745886654479
Current ratio: 1.0219837398373983
Quick ratio: 1.021170731707317
Interest coverage ratio: -201.9714285714286
COGS to revenue (%): 80.74585964494221
Free cash flow (dilution-adjusted): -2435106.3829787234
Buyback yield (%): 0
Retained earnings: -6385106.382978723
Inventory turnover: 813.24
Receivables turnover: 1.979325524722899
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -34.781539067112774
FCF margin (%): -9.090909090909092
Rule of 40 score: -9.090909090909092
Financial ratios for ALLIX.PA — annual report dated 2023-12-31
Total revenue: 33533333.333333332
Gross profit: 14505555.555555556
Operating income: -10612222.222222222
Net income: -9482222.222222222
Capital expenditures: 5212222.222222222
Operating cash flow: -3864444.4444444445
Depreciation & amortization: 5846666.666666667
Net tangible assets: -4533333.333333333
Owner earnings: -8847777.777777776
Buffett classification: The Gruesome
Stock price: 10.266666666666667
Shares outstanding: 6745610
Book value: 16811111.111111112
P/B ratio: 4.119592623925975
Market cap (USD): 69254929.33333334
Debt to equity: 0.5918043621943159
Current ratio: 4.305124043589149
Quick ratio: 4.304428472061211
Interest coverage ratio: -46.36407766990291
COGS to revenue (%): 56.74287607687209
Free cash flow (dilution-adjusted): -9111111.11111111
Buyback yield (%): 0
Retained earnings: -9482222.222222222
Inventory turnover: 2854.1666666666665
Receivables turnover: 2.1517182375588195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.163707136981074
FCF margin (%): -27.170311464546053
Revenue growth (%): 25.188980234851787
Rule of 40 score: -1.9813312296942662
Financial ratios for ALLIX.PA — annual report dated 2024-12-31
Total revenue: 35507291.66666667
Gross profit: 18784375
Operating income: -5871875
Net income: -4472916.666666667
Capital expenditures: 6696875
Operating cash flow: 1613541.6666666667
Depreciation & amortization: 5240625
Net tangible assets: -11355208.333333334
Owner earnings: -5929166.666666667
Buffett classification: The Gruesome
Stock price: 10.302083333333334
Shares outstanding: 6745610
Book value: 10243750
P/B ratio: 6.7840230730119995
Market cap (USD): 69493836.35416667
Debt to equity: 0.8416717510677242
Current ratio: 3.715880446525027
Quick ratio: 3.715400312087384
Interest coverage ratio: -12.416299559471366
COGS to revenue (%): 47.09713380467627
Free cash flow (dilution-adjusted): -5085416.666666667
Buyback yield (%): 0.6400447723159812
Retained earnings: -4472916.666666667
Inventory turnover: 4013.5
Receivables turnover: 2.241828345938836
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.28559597236449
FCF margin (%): -14.322175609469884
Revenue growth (%): 5.886555666003995
Rule of 40 score: -8.43561994346589
Financial ratios for ALLIX.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -11355208.333333334
Buffett classification: The Gruesome
Stock price: 10.302083333333334
Shares outstanding: 6745610
Book value: 10243750
P/B ratio: 6.7840230730119995
Market cap (USD): 69493836.35416667
Debt to equity: 0.8416717510677242
Current ratio: 3.715880446525027
Quick ratio: 3.715400312087384
Buyback yield (%): 0
Retained earnings: -4472916.666666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMX.V — annual report dated 2021-12-31
Gross profit: -80295.27559055117
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.2913385826771653
Shares outstanding: 155579058
Market cap (USD): 356484298.2519685
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMX.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -99459.5588235294
Operating income: -2688933.8235294116
Net income: 104452.94117647059
Capital expenditures: 21958566.176470585
Operating cash flow: -2852900.7352941176
Depreciation & amortization: 99459.5588235294
Net tangible assets: 65406848.52941176
Owner earnings: -21754653.676470585
Return on net tangible assets (%): -33.26051348688369
Buffett classification: The Gruesome
Stock price: 1.2499999999999998
P/E ratio: 1861.8319437404964
Shares outstanding: 155579058
Book value: 65406848.52941176
P/B ratio: 2.973294492434537
Market cap (USD): 194473822.49999997
Debt to equity: 0
Current ratio: 2.9246349359312713
Quick ratio: 2.9246349359312713
Free cash flow (dilution-adjusted): -25065728.676470585
Buyback yield (%): 0
Retained earnings: -20287170.588235293
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.6642852027617403
Rule of 40 score: 0
Financial ratios for AMX.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -2511058.333333333
Net income: 515277.2727272727
Capital expenditures: 18628661.363636363
Operating cash flow: -1815711.3636363635
Depreciation & amortization: 141477.2727272727
Net tangible assets: 67904151.51515152
Owner earnings: -17971906.818181816
Return on net tangible assets (%): -26.4665803447551
Buffett classification: The Gruesome
Stock price: 1.0378787878787878
P/E ratio: 313.369544287718
Shares outstanding: 155579058
Book value: 67904151.51515152
P/B ratio: 2.3779430349016906
Market cap (USD): 161472204.13636363
Debt to equity: 0
Current ratio: 2.1559434299791342
Quick ratio: 2.1559434299791342
Free cash flow (dilution-adjusted): -20444372.727272727
Buyback yield (%): 0
Retained earnings: -20386656.06060606
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.1271712719555644
Rule of 40 score: 0
Financial ratios for AMX.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8666666666666666
Shares outstanding: 155579058
Market cap (USD): 134835183.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMX.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7692307692307693
Shares outstanding: 155579058
Market cap (USD): 119676198.46153846
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMX.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -2497157.3426573426
Net income: -517170.6293706294
Capital expenditures: 14746403.496503497
Operating cash flow: -984418.8811188812
Depreciation & amortization: 140235.66433566433
Net tangible assets: 78979397.2027972
Owner earnings: -15123338.461538462
Return on net tangible assets (%): -19.14846022780589
Buffett classification: The Gruesome
Stock price: 0.7692307692307693
Shares outstanding: 155579058
Book value: 78979397.2027972
P/B ratio: 1.515283766401042
Market cap (USD): 119676198.46153846
Debt to equity: 0
Current ratio: 3.4898123129579592
Quick ratio: 3.4898123129579592
Free cash flow (dilution-adjusted): -15730822.377622379
Buyback yield (%): 0
Retained earnings: -19876330.76923077
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.679954610303791
Rule of 40 score: 0
Financial ratios for AMX.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -687447.5524475524
Net income: -156722.37762237762
Capital expenditures: 2005732.1678321678
Operating cash flow: -324986.013986014
Depreciation & amortization: 36411.18881118881
Net tangible assets: 78822674.82517482
Owner earnings: -2126043.356643357
Return on net tangible assets (%): -2.6972484267488084
Buffett classification: The Gruesome
Stock price: 0.6223776223776224
Shares outstanding: 155579058
Book value: 78822674.82517482
P/B ratio: 1.228439968886522
Market cap (USD): 96828924.20979021
Debt to equity: 0
Current ratio: 3.2692562028036973
Quick ratio: 3.2692562028036973
Free cash flow (dilution-adjusted): -2330718.181818182
Buyback yield (%): 0
Retained earnings: -20033053.14685315
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7390131678005983
Rule of 40 score: 0
Financial ratios for AMX.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -653543.795620438
Net income: 54075.91240875912
Capital expenditures: 2298224.0875912406
Operating cash flow: -810498.5401459853
Depreciation & amortization: 37892.700729927004
Net tangible assets: 83368984.67153284
Owner earnings: -2206255.4744525547
Return on net tangible assets (%): -2.6463744078748537
Buffett classification: The Gruesome
Stock price: 1.0802919708029197
P/E ratio: 777.0132749311593
Shares outstanding: 155579058
Book value: 83368984.67153284
P/B ratio: 2.015987214485907
Market cap (USD): 168070807.18248177
Debt to equity: 0
Current ratio: 3.1087896690953896
Quick ratio: 3.1087896690953896
Free cash flow (dilution-adjusted): -3108722.627737226
Buyback yield (%): 0
Retained earnings: -20856337.22627737
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6655871777886753
Rule of 40 score: 0
Financial ratios for AMX.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -868837.4100719425
Net income: -410248.9208633094
Capital expenditures: 1535133.8129496404
Operating cash flow: -210556.8345323741
Depreciation & amortization: 33608.63309352518
Net tangible assets: 106730243.88489209
Owner earnings: -1911774.1007194247
Return on net tangible assets (%): -1.791220586716977
Buffett classification: The Gruesome
Stock price: 2.0575539568345325
Shares outstanding: 155579058
Book value: 106730243.88489209
P/B ratio: 2.9992652010964047
Market cap (USD): 320112306.38848925
Debt to equity: 0
Current ratio: 9.428349224506517
Quick ratio: 9.428349224506517
Free cash flow (dilution-adjusted): -1745690.6474820145
Buyback yield (%): 0
Retained earnings: -21842915.10791367
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7160439325127271
Rule of 40 score: 0
Financial ratios for AMX.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -5414232.116788321
Net income: -5656678.832116788
Capital expenditures: 2558475.912408759
Operating cash flow: -1280229.9270072991
Depreciation & amortization: 34881.75182481752
Net tangible assets: 105968806.56934306
Owner earnings: -8180272.9927007295
Return on net tangible assets (%): -7.719510351706929
Buffett classification: The Gruesome
Stock price: 2.9197080291970803
Shares outstanding: 155579058
Book value: 105968806.56934306
P/B ratio: 4.286595645674962
Market cap (USD): 454245424.81751823
Debt to equity: 0
Current ratio: 4.3473561697495935
Quick ratio: 4.3473561697495935
Free cash flow (dilution-adjusted): -3838705.8394160583
Buyback yield (%): 0
Retained earnings: -27783395.620437954
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.447053836381001
Rule of 40 score: 0
Financial ratios for AMX.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -7666853.284671532
Net income: -6382997.080291971
Capital expenditures: 8507381.02189781
Operating cash flow: -2643578.1021897807
Depreciation & amortization: 144879.5620437956
Net tangible assets: 105968806.56934306
Owner earnings: -14745498.540145986
Return on net tangible assets (%): -13.914942535940462
Buffett classification: The Gruesome
Stock price: 2.9197080291970803
Shares outstanding: 155579058
Book value: 105968806.56934306
P/B ratio: 4.286595645674962
Market cap (USD): 454245424.81751823
Debt to equity: 0
Current ratio: 4.3473561697495935
Quick ratio: 4.3473561697495935
Free cash flow (dilution-adjusted): -14961562.04379562
Buyback yield (%): 0
Retained earnings: -27783395.620437954
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.297275140245306
Rule of 40 score: 0
Financial ratios for ANTO.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1577027027027027
Shares outstanding: 985856695
Market cap (USD): 155472265.27905405
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANTO.L — annual report dated 2022-12-31
Total revenue: 7062650602.409639
Gross profit: 2926867469.879518
Operating income: 1992048192.7710845
Net income: 2355783132.5301204
Capital expenditures: 2263855421.686747
Operating cash flow: 2261325301.204819
Depreciation & amortization: 1374819277.1084337
Net tangible assets: 10394578313.253012
Owner earnings: 1466746987.951807
Return on net tangible assets (%): 14.110692552883219
Capex to operating income (%): 113.64461110439095
Buffett classification: The Gruesome
Stock price: 0.17361445783132531
P/E ratio: 0.07265480987546669
Shares outstanding: 985856695
Book value: 14029397590.361446
P/B ratio: 0.012200023165598916
Market cap (USD): 171158975.60180724
Debt to equity: 0.2812081343821923
Current ratio: 3.252023913314236
Quick ratio: 2.8110599078341014
Effective tax rate (%): 23.588260580718273
Interest coverage ratio: 17.313089005235604
COGS to revenue (%): 58.55851245308769
SG&A to revenue (%): 9.534288638689867
Free cash flow (dilution-adjusted): -2771084.3373493976
Buyback yield (%): 0
Retained earnings: 10040361445.783133
Inventory turnover: 4.847761615591018
Receivables turnover: 5.879049242804132
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.94077859612205
FCF margin (%): -0.03923575571477311
Rule of 40 score: -0.03923575571477311
Financial ratios for ANTO.L — annual report dated 2023-12-31
Total revenue: 8005696202.531645
Gross profit: 3364683544.3037972
Operating income: 2289240506.329114
Net income: 1644810126.5822785
Capital expenditures: 2695189873.4177213
Operating cash flow: 2953164556.962025
Depreciation & amortization: 1533291139.2405062
Net tangible assets: 11331518987.341772
Owner earnings: 482911392.40506315
Return on net tangible assets (%): 4.261665121370881
Capex to operating income (%): 117.732927840752
Buffett classification: The Gruesome
Stock price: 0.20455696202531645
P/E ratio: 0.12260615815915038
Shares outstanding: 985856695
Book value: 15251139240.50633
P/B ratio: 0.013222871245310578
Market cap (USD): 201663850.52151898
Debt to equity: 0.33836028020318043
Current ratio: 2.3712145434613805
Quick ratio: 2.064723884346595
Effective tax rate (%): 33.88959552276774
Interest coverage ratio: 14.897034596375617
COGS to revenue (%): 57.97138113684876
SG&A to revenue (%): 9.779429203889636
Free cash flow (dilution-adjusted): 257974683.54430377
Buyback yield (%): 0
Retained earnings: 10833417721.518988
Inventory turnover: 5.464083457526081
Receivables turnover: 6.656667719187454
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.359207006570092
FCF margin (%): 3.222389121669697
Revenue growth (%): 13.352573321413585
Rule of 40 score: 16.574962443083283
Financial ratios for ANTO.L — annual report dated 2024-12-31
Total revenue: 8266750000
Gross profit: 3130500000
Operating income: 2078375000
Net income: 1645000000
Capital expenditures: 3017875000
Operating cash flow: 2856625000
Depreciation & amortization: 1960250000
Net tangible assets: 11827750000
Owner earnings: 587375000
Return on net tangible assets (%): 4.966075542685633
Capex to operating income (%): 145.20358453118422
Buffett classification: The Gruesome
Stock price: 0.193625
P/E ratio: 0.11604042709384498
Shares outstanding: 985856695
Book value: 16192750000
P/B ratio: 0.011788393112311064
Market cap (USD): 190886502.56937498
Debt to equity: 0.4129162742585416
Current ratio: 2.2188074220861105
Quick ratio: 1.8854981084489282
Effective tax rate (%): 36.45888658200956
Interest coverage ratio: 5.023262839879154
COGS to revenue (%): 62.13143012671243
SG&A to revenue (%): 8.789729942238486
Free cash flow (dilution-adjusted): -161625000
Buyback yield (%): 0
Retained earnings: 11489250000
Inventory turnover: 4.441681980326451
Receivables turnover: 9.453116066323613
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.372357674451393
FCF margin (%): -1.9551214201469744
Revenue growth (%): 3.2608506601312452
Rule of 40 score: 1.3057292399842708
Financial ratios for ANTO.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 11827750000
Buffett classification: The Gruesome
Stock price: 0.193625
Shares outstanding: 985856695
Book value: 16192750000
P/B ratio: 0.011788393112311064
Market cap (USD): 190886502.56937498
Debt to equity: 0.4129162742585416
Current ratio: 2.2188074220861105
Quick ratio: 1.8854981084489282
Buyback yield (%): 0
Retained earnings: 11489250000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANTO.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 13322328767.123287
Buffett classification: The Gruesome
Stock price: 0.24424657534246574
Shares outstanding: 985856695
Book value: 18586712328.76712
P/B ratio: 0.01295506796861066
Market cap (USD): 240792121.53219178
Debt to equity: 0.462379222157529
Current ratio: 3.6173961218836563
Quick ratio: 3.167534626038781
Buyback yield (%): 0
Retained earnings: 12932602739.726028
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZI.AX — annual report dated 2021-06-30
Operating income: -4312012.030075188
Net income: -4043256.390977443
Capital expenditures: 14712.03007518797
Depreciation & amortization: 29093.984962406015
Net tangible assets: 2863760.902255639
Owner earnings: -4028874.436090225
Return on net tangible assets (%): -140.68473499016224
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 795206754
Book value: 2863760.902255639
P/B ratio: 12.526879906070203
Market cap (USD): 35873988.90225564
Debt to equity: 0.010843567084873407
Current ratio: 3.0351006085859975
Quick ratio: 3.0351006085859975
Interest coverage ratio: -2906.728839330968
Free cash flow (dilution-adjusted): -3717013.5338345864
Buyback yield (%): 0.8387776679606354
Retained earnings: -35581858.64661654
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -149.51041975975517
Rule of 40 score: 0
Financial ratios for AZI.AX — annual report dated 2022-06-30
Operating income: -3609451.724137931
Net income: -3906800
Capital expenditures: 34859.31034482759
Depreciation & amortization: 12869.655172413793
Net tangible assets: 2765545.5172413792
Owner earnings: -3928789.6551724137
Return on net tangible assets (%): -142.06201382978378
Buffett classification: The Gruesome
Stock price: 0.055172413793103454
Shares outstanding: 795206754
Book value: 2765545.5172413792
P/B ratio: 15.864311691576225
Market cap (USD): 43873476.08275863
Debt to equity: 0.015779140412778822
Current ratio: 3.626373080923832
Quick ratio: 3.626373080923832
Interest coverage ratio: -4092.0289288506647
Free cash flow (dilution-adjusted): -3547475.1724137934
Buyback yield (%): 0.2122388286455625
Retained earnings: -36503713.10344828
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -129.63728988794438
Rule of 40 score: 0
Financial ratios for AZI.AX — annual report dated 2023-06-30
Operating income: -2200776.158940397
Net income: -1876913.9072847683
Capital expenditures: 3137.0860927152316
Depreciation & amortization: 3468.2119205298013
Net tangible assets: 3049460.927152318
Owner earnings: -1876582.7814569536
Return on net tangible assets (%): -61.53818088790419
Buffett classification: The Gruesome
Stock price: 0.039735099337748346
Shares outstanding: 795206754
Book value: 3049460.9271523175
P/B ratio: 10.361706583250195
Market cap (USD): 31597619.36423841
Debt to equity: 0
Current ratio: 2.1984057728404385
Quick ratio: 2.1984057728404385
Free cash flow (dilution-adjusted): -2533942.3841059604
Buyback yield (%): 0
Retained earnings: -36930148.344370864
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -72.11946688611725
Rule of 40 score: 0
Financial ratios for BRAI.L — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.022083333333333337
Shares outstanding: 61460138
Market cap (USD): 1357244.7141666668
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRAI.L — annual report dated 2022-10-31
Total revenue: 15159302.325581396
Net income: 14151162.790697675
Capital expenditures: 0
Operating cash flow: 2190697.6744186045
Net tangible assets: 198937209.30232558
Owner earnings: 14151162.790697675
Return on net tangible assets (%): 7.113381574179069
Buffett classification: The Gruesome
Stock price: 0.01918604651162791
P/E ratio: 0.08332722078882498
Shares outstanding: 61460138
Book value: 198937209.30232558
P/B ratio: 0.005927383169867786
Market cap (USD): 1179177.0662790698
Debt to equity: 0.022526682487170192
Effective tax rate (%): 3.6192286370475966
COGS to revenue (%): 0
SG&A to revenue (%): 3.9733067423487
Free cash flow (dilution-adjusted): 2190697.6744186045
Buyback yield (%): 0
Receivables turnover: 4.2856673241288625
Capitalized R&D asset: 0
FCF margin (%): 14.451177418117664
Rule of 40 score: 14.451177418117664
Financial ratios for BRAI.L — annual report dated 2023-10-31
Total revenue: -10284146.341463415
Net income: -11531707.317073172
Capital expenditures: 0
Operating cash flow: 14306097.560975611
Net tangible assets: 188767073.17073172
Owner earnings: -11531707.317073172
Return on net tangible assets (%): -6.108961231095233
Buffett classification: The Gruesome
Stock price: 0.018414634146341466
Shares outstanding: 61460138
Book value: 188767073.17073172
P/B ratio: 0.005995568701910343
Market cap (USD): 1131765.9558536587
Debt to equity: 0
Free cash flow (dilution-adjusted): 14306097.560975611
Buyback yield (%): 45.57953487366491
Receivables turnover: -3.4703703703703703
Capitalized R&D asset: 0
Revenue growth (%): -167.8404989925484
Rule of 40 score: -167.8404989925484
Financial ratios for BRAI.L — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 201385714.28571427
Buffett classification: The Gruesome
Stock price: 0.022337662337662337
Shares outstanding: 61460138
Book value: 201385714.2857143
P/B ratio: 0.006817145966582186
Market cap (USD): 1372875.80987013
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRAI.L — annual report dated 2024-10-31
Total revenue: 30577922.077922076
Net income: 29314285.714285713
Capital expenditures: 0
Operating cash flow: 28568831.16883117
Net tangible assets: 201385714.28571427
Owner earnings: 29314285.714285713
Return on net tangible assets (%): 14.556288572036605
Buffett classification: The Gruesome
Stock price: 0.022337662337662337
P/E ratio: 0.04683299546340599
Shares outstanding: 61460138
Book value: 201385714.2857143
P/B ratio: 0.006817145966582186
Market cap (USD): 1372875.80987013
Debt to equity: 0
Effective tax rate (%): 1.865136298421808
COGS to revenue (%): 0
SG&A to revenue (%): 2.4930983223614356
Free cash flow (dilution-adjusted): 28568831.16883117
Buyback yield (%): 1492.3645344330034
Receivables turnover: 523.2222222222222
Capitalized R&D asset: 0
FCF margin (%): 93.42960288808665
Rule of 40 score: 93.42960288808665
Financial ratios for BRAI.L — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 152336000
Buffett classification: The Gruesome
Stock price: 0.0236
Shares outstanding: 61460138
Book value: 152336000
P/B ratio: 0.009521447699821448
Market cap (USD): 1450459.2567999999
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRAI.L — annual report dated 2025-10-31
Total revenue: 15518421.05263158
Net income: 14413157.894736841
Capital expenditures: 0
Operating cash flow: 48214473.684210524
Net tangible assets: 170393421.0526316
Owner earnings: 14413157.894736841
Return on net tangible assets (%): 8.458752577239977
Buffett classification: The Gruesome
Stock price: 0.027368421052631577
P/E ratio: 0.11670356677012964
Shares outstanding: 61460138
Book value: 170393421.0526316
P/B ratio: 0.009871665961899319
Market cap (USD): 1682066.934736842
Debt to equity: 0
Effective tax rate (%): 2.9588944011339473
COGS to revenue (%): 0
SG&A to revenue (%): 4.434458199084281
Free cash flow (dilution-adjusted): 48214473.684210524
Buyback yield (%): 2381.7814301786207
Capitalized R&D asset: 0
FCF margin (%): 310.69187722570797
Revenue growth (%): -49.249589252383444
Rule of 40 score: 261.44228797332454
Financial ratios for BRAI.L — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 170393421.0526316
Buffett classification: The Gruesome
Stock price: 0.027368421052631577
Shares outstanding: 61460138
Book value: 170393421.0526316
P/B ratio: 0.009871665961899319
Market cap (USD): 1682066.934736842
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGM.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 221.92045454545453
Shares outstanding: 166070813
Market cap (USD): 36854510307.69318
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGM.DE — annual report dated 2022-12-31
Total revenue: 23398936170.21277
Gross profit: 6204255319.148936
Operating income: 2722340425.531915
Net income: 1648936170.212766
Capital expenditures: 301063829.78723407
Operating cash flow: 2677659574.4680853
Depreciation & amortization: 764893617.0212766
Net tangible assets: -2413829787.2340426
Owner earnings: 2112765957.4468086
Return on net tangible assets (%): -87.5275451740855
Capex to operating income (%): 11.059007424775302
Buffett classification: The Great
Stock price: 151.7553191489362
P/E ratio: 15.283871919000003
Shares outstanding: 166070813
Book value: 10364893617.021278
P/B ratio: 2.431489425685107
Market cap (USD): 25202129228.1383
Debt to equity: 0.7746074104485271
Current ratio: 1.2823310601363918
Quick ratio: 1.2823310601363918
Effective tax rate (%): 31.360424028268547
Interest coverage ratio: 16.29936305732484
COGS to revenue (%): 73.48488292793817
SG&A to revenue (%): 13.480336440100022
Free cash flow (dilution-adjusted): 2194680851.06383
Buyback yield (%): 3.486703033306488
Retained earnings: 4927659574.468085
Receivables turnover: 6.607089215980775
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.695072929826575
FCF margin (%): 9.379404410093201
Rule of 40 score: 9.379404410093201
Financial ratios for CGM.DE — annual report dated 2023-12-31
Total revenue: 25024444444.444443
Gross profit: 6720000000
Operating income: 2871111111.111111
Net income: 1853333333.3333333
Capital expenditures: 282222222.2222222
Operating cash flow: 2805555555.5555553
Depreciation & amortization: 777777777.7777778
Net tangible assets: -1730000000
Owner earnings: 2348888888.888889
Return on net tangible assets (%): -135.77392421323057
Capex to operating income (%): 9.829721362229101
Buffett classification: The Great
Stock price: 196.8222222222222
P/E ratio: 17.63656104005995
Shares outstanding: 166070813
Book value: 11636666666.666666
P/B ratio: 2.8089166251141022
Market cap (USD): 32686426460.911106
Debt to equity: 0.6297145039625704
Current ratio: 1.344185404883432
Quick ratio: 1.344185404883432
Effective tax rate (%): 27.17013888888889
Interest coverage ratio: 13.89247311827957
COGS to revenue (%): 73.14625699316224
SG&A to revenue (%): 13.573394902761745
Free cash flow (dilution-adjusted): 2237777777.7777777
Buyback yield (%): 2.9777905960363045
Retained earnings: 6212222222.222222
Receivables turnover: 6.85392574558734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.807174373961377
FCF margin (%): 8.942367462925139
Revenue growth (%): 6.946932383622522
Rule of 40 score: 15.889299846547662
Financial ratios for CGM.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -1463541666.6666667
Buffett classification: The Gruesome
Stock price: 154.34375
Shares outstanding: 166070813
Book value: 12288541666.666668
P/B ratio: 2.085844906519454
Market cap (USD): 25631992043.96875
Debt to equity: 0.5151309654997033
Current ratio: 1.2074198988195615
Quick ratio: 1.2074198988195615
Buyback yield (%): 0
Retained earnings: 7512500000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGM.DE — annual report dated 2024-12-31
Total revenue: 23016666666.666668
Gross profit: 6304166666.666667
Operating income: 2637500000
Net income: 1746875000
Capital expenditures: 322916666.6666667
Operating cash flow: 2631250000
Depreciation & amortization: 711458333.3333334
Net tangible assets: -1463541666.6666667
Owner earnings: 2135416666.6666667
Return on net tangible assets (%): -145.90747330960855
Capex to operating income (%): 12.243285939968406
Buffett classification: The Great
Stock price: 154.34375
P/E ratio: 14.673054479552771
Shares outstanding: 166070813
Book value: 12288541666.666668
P/B ratio: 2.085844906519454
Market cap (USD): 25631992043.96875
Debt to equity: 0.5151309654997033
Current ratio: 1.2074198988195615
Quick ratio: 1.2074198988195615
Effective tax rate (%): 28.746306458421273
Interest coverage ratio: 13.836065573770492
COGS to revenue (%): 72.61042722664736
SG&A to revenue (%): 14.111151339608979
Free cash flow (dilution-adjusted): 2018750000
Buyback yield (%): 4.019228515544671
Retained earnings: 7512500000
Receivables turnover: 6.823965410747375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.105063784747365
FCF margin (%): 8.770818247646632
Revenue growth (%): -8.023266139774432
Rule of 40 score: 0.7475521078722007
Financial ratios for CGM.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -1618823529.4117649
Buffett classification: The Gruesome
Stock price: 166.63529411764705
Shares outstanding: 166070813
Book value: 12935294117.647058
P/B ratio: 2.1393606142173716
Market cap (USD): 27673258768.611763
Debt to equity: 0.5522510231923602
Current ratio: 1.106721331842465
Quick ratio: 1.106721331842465
Buyback yield (%): 0
Retained earnings: 7540000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRS — annual report dated 2021-12-31
Capital expenditures: 1289000
Buffett classification: The Gruesome
Stock price: 15.96
Shares outstanding: 154249900
Market cap (USD): 2461828404
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRS — annual report dated 2022-12-31
Total revenue: 211042000
Gross profit: 140959000
Operating income: -256880000
Net income: -291754000
Capital expenditures: 2039000
Operating cash flow: -241124000
Depreciation & amortization: 3699000
Net tangible assets: -143349000
Owner earnings: -290094000
Buffett classification: The Gruesome
Stock price: 7.92
Shares outstanding: 154249900
Book value: -137418000
Market cap (USD): 1221659208
Debt to equity: -3.4960631067254653
Current ratio: 2.74874183454223
Quick ratio: 2.469054176820915
Interest coverage ratio: -7.910328262610088
COGS to revenue (%): 33.20808180362203
R&D to revenue (%): 94.46366126173938
SG&A to revenue (%): 94.04810416883844
Free cash flow (dilution-adjusted): -291861000
Buyback yield (%): 0
Retained earnings: -1341608000
Inventory turnover: 1.8066819623108452
Receivables turnover: 1.9191917354770651
Capitalized R&D asset: 199358000
ROCI (R&D-adjusted, %): -22.89421021302737
FCF margin (%): -138.29522085651197
Rule of 40 score: -138.29522085651197
Financial ratios for CHRS — annual report dated 2023-12-31
Total revenue: 257244000
Gross profit: 98252000
Operating income: -203199000
Net income: -237892000
Capital expenditures: 559000
Operating cash flow: -174884000
Depreciation & amortization: 3791000
Net tangible assets: -265098000
Owner earnings: -234660000
Buffett classification: The Gruesome
Stock price: 3.33
Shares outstanding: 154249900
Book value: -193425000
Market cap (USD): 513652167
Debt to equity: -2.485935116970402
Current ratio: 1.433612341042466
Quick ratio: 1.2449129067941442
Interest coverage ratio: -5.012061565783632
COGS to revenue (%): 61.80591189687612
R&D to revenue (%): 42.54171137130506
SG&A to revenue (%): 74.64314036478984
Free cash flow (dilution-adjusted): -217994000
Buyback yield (%): 0
Retained earnings: -1579500000
Inventory turnover: 2.5396054628224585
Receivables turnover: 0.9874175693415528
Capitalized R&D asset: 243005860
ROCI (R&D-adjusted, %): -36.36838028490285
Rosenberg metric: -0.21422265472165652
FCF margin (%): -84.74211254684269
Revenue growth (%): 21.892324750523592
Rule of 40 score: -62.8497877963191
Financial ratios for CHRS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.04
Shares outstanding: 154249900
Market cap (USD): 160419896
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.38
Shares outstanding: 154249900
Market cap (USD): 212864861.99999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRS — annual report dated 2024-12-31
Total revenue: 26389000
Gross profit: 17662000
Operating income: -199653000
Net income: 28507000
Capital expenditures: 0
Operating cash flow: -20440000
Depreciation & amortization: 5276000
Net tangible assets: -185636000
Owner earnings: 33783000
Return on net tangible assets (%): -18.198517528927578
Buffett classification: The Gruesome
Stock price: 1.38
P/E ratio: 7.4671084996667485
Shares outstanding: 154249900
Book value: -131990000
Market cap (USD): 212864861.99999997
Debt to equity: -2.0448821880445487
Current ratio: 1.2070881083889025
Quick ratio: 1.1922213858880986
Interest coverage ratio: -18.600055897149247
COGS to revenue (%): 33.0705975974838
R&D to revenue (%): 347.9972715904354
SG&A to revenue (%): 475.5087347000644
Free cash flow (dilution-adjusted): -48242000
Buyback yield (%): 0
Retained earnings: -1550993000
Inventory turnover: 2.0743998098407417
Receivables turnover: 0.21571272091160265
Capitalized R&D asset: 230943260
ROCI (R&D-adjusted, %): -60.87395176762852
Rosenberg metric: -0.7364121495668702
FCF margin (%): -182.81101974307475
Revenue growth (%): -89.7416460636594
Rule of 40 score: -272.5526658067341
Financial ratios for CHRS — quarterly report dated 2025-03-31
Total revenue: 7599000
Gross profit: 4946000
Operating income: -45435000
Net income: -56569000
Capital expenditures: 0
Operating cash flow: -25826000
Depreciation & amortization: 1046000
Net tangible assets: -236449000
Owner earnings: -55523000
Buffett classification: The Gruesome
Stock price: 0.81
Shares outstanding: 154249900
Book value: -183470000
Market cap (USD): 124942419.00000001
Debt to equity: -1.4712323540633345
Current ratio: 1.2161722382980058
Quick ratio: 1.2023784317877055
Interest coverage ratio: -21.132558139534883
COGS to revenue (%): 34.91248848532702
R&D to revenue (%): 320.5158573496513
SG&A to revenue (%): 342.47927358863006
Free cash flow (dilution-adjusted): -31198000
Buyback yield (%): 0
Retained earnings: -1607562000
Inventory turnover: 0.7541216600341103
Receivables turnover: 0.12170862963674803
Capitalized R&D asset: 24356000
ROCI (R&D-adjusted, %): -20.79902170299663
FCF margin (%): -410.5540202658244
Rule of 40 score: -410.5540202658244
Financial ratios for CHRS — quarterly report dated 2025-06-30
Total revenue: 10254000
Gross profit: 6859000
Operating income: -45486000
Net income: 297767000
Capital expenditures: 0
Operating cash flow: -46632000
Depreciation & amortization: 1016000
Net tangible assets: 67515000
Owner earnings: 298783000
Return on net tangible assets (%): 442.5431385618011
Buffett classification: The Gruesome
Stock price: 0.73
P/E ratio: 0.4668464373668107
Shares outstanding: 154249900
Book value: 119827000
P/B ratio: 0.9397083044722809
Market cap (USD): 112602427
Debt to equity: 0.3424019628297462
Current ratio: 1.4340918606361672
Quick ratio: 1.4170693160429844
Interest coverage ratio: -19.976284584980238
COGS to revenue (%): 33.109030622196215
R&D to revenue (%): 256.5437877901307
SG&A to revenue (%): 253.93992588258243
Free cash flow (dilution-adjusted): -52053000
Buyback yield (%): 0
Retained earnings: -1309795000
Inventory turnover: 0.7522712164857079
Receivables turnover: 0.08570783774521686
Capitalized R&D asset: 42624520
ROCI (R&D-adjusted, %): -16.623225849111584
Rosenberg metric: 0.07854327475775989
FCF margin (%): -507.63604447045054
Revenue growth (%): 34.938807737860245
Rule of 40 score: -472.6972367325903
Financial ratios for CHRS — quarterly report dated 2025-09-30
Total revenue: 11571000
Gross profit: 7850000
Operating income: -44333000
Net income: -35531000
Capital expenditures: 0
Operating cash flow: -46339000
Depreciation & amortization: 966000
Net tangible assets: 38290000
Owner earnings: -34565000
Return on net tangible assets (%): -90.27161138678507
Buffett classification: The Gruesome
Stock price: 1.64
P/E ratio: 1.2299972090806983
Shares outstanding: 154249900
Book value: 87774000
P/B ratio: 2.8820588784833774
Market cap (USD): 252969835.99999997
Debt to equity: 0.4636224850183426
Current ratio: 1.2332023318092924
Quick ratio: 1.2277232755553296
Interest coverage ratio: -19.06795698924731
COGS to revenue (%): 32.15798115979604
R&D to revenue (%): 235.51983406792846
SG&A to revenue (%): 215.46106645925155
Free cash flow (dilution-adjusted): -49728000
Buyback yield (%): 0
Retained earnings: -1345326000
Inventory turnover: 1.81689453125
Receivables turnover: 0.046192354368932036
Capitalized R&D asset: 52914500
ROCI (R&D-adjusted, %): -22.00516407568412
Rosenberg metric: 0.03767201398920399
FCF margin (%): -429.7640653357532
Revenue growth (%): 12.843768285547103
Rule of 40 score: -416.92029705020605
Financial ratios for CHRS — quarterly report dated 2025-12-31
Total revenue: 12748000
Gross profit: 8703000
Operating income: -45880000
Net income: -37643000
Capital expenditures: 0
Operating cash flow: -19716000
Depreciation & amortization: 896000
Net tangible assets: 14775000
Owner earnings: -36747000
Return on net tangible assets (%): -248.71065989847713
Buffett classification: The Gruesome
Stock price: 1.42
P/E ratio: 1.3035926891396468
Shares outstanding: 154249900
Book value: 61014000
P/B ratio: 3.589911462942931
Market cap (USD): 219034858
Debt to equity: 0.6610941751073525
Current ratio: 1.4569483210691025
Quick ratio: 1.4345907694042686
Interest coverage ratio: -20.400177856825255
COGS to revenue (%): 31.73046752431754
R&D to revenue (%): 242.97144650141198
SG&A to revenue (%): 185.1976780671478
Free cash flow (dilution-adjusted): -22500000
Buyback yield (%): 0
Retained earnings: -1382969000
Inventory turnover: 1.275220680958386
Receivables turnover: 0.6921489846888913
Capitalized R&D asset: 57913820
ROCI (R&D-adjusted, %): -24.706463321673407
Rosenberg metric: 0.03130045501247615
FCF margin (%): -176.49827423909633
Revenue growth (%): 10.171981678333765
Rule of 40 score: -166.32629256076257
Financial ratios for CHRS — annual report dated 2025-12-31
Total revenue: 42172000
Gross profit: 28358000
Operating income: -181134000
Net income: 168024000
Capital expenditures: 0
Operating cash flow: -138513000
Depreciation & amortization: 3924000
Net tangible assets: 14775000
Owner earnings: 171948000
Return on net tangible assets (%): 1163.7766497461928
Buffett classification: The Gruesome
Stock price: 1.42
P/E ratio: 1.3035926891396468
Shares outstanding: 154249900
Book value: 61014000
P/B ratio: 3.589911462942931
Market cap (USD): 219034858
Debt to equity: 0.6610941751073525
Current ratio: 1.4569483210691025
Quick ratio: 1.4345907694042686
Interest coverage ratio: -20.12376402621931
COGS to revenue (%): 32.75633121502419
R&D to revenue (%): 258.19975339087546
SG&A to revenue (%): 238.55638812482215
Free cash flow (dilution-adjusted): -155479000
Buyback yield (%): 0
Retained earnings: -1382969000
Inventory turnover: 4.354981084489281
Receivables turnover: 2.2897165816049516
Capitalized R&D asset: 206529990
ROCI (R&D-adjusted, %): -54.375635719288496
Rosenberg metric: 0.11647229209543411
FCF margin (%): -368.6782699421417
Revenue growth (%): 59.80901133047861
Rule of 40 score: -308.8692586116631
Financial ratios for CPAC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.68
Shares outstanding: 84773690
Market cap (USD): 396740869.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPAC — annual report dated 2022-12-31
Total revenue: 558244327.1767809
Gross profit: 172039841.68865436
Operating income: 93751451.18733509
Net income: 46656464.37994723
Capital expenditures: 42248284.960422166
Operating cash flow: 29503693.931398418
Depreciation & amortization: 36553825.85751979
Net tangible assets: 301608179.4195251
Owner earnings: 40962005.277044855
Return on net tangible assets (%): 13.581198413080276
Capex to operating income (%): 45.06413972835601
Buffett classification: The Good
Stock price: 4.26
P/E ratio: 7.740319036159432
Shares outstanding: 84773690
Book value: 315339050.1319262
P/B ratio: 1.1452305676982095
Market cap (USD): 361135919.4
Debt to equity: 1.3366908340898724
Current ratio: 1.246883193322275
Quick ratio: 0.3184047657267197
Effective tax rate (%): 32.61641643167441
Interest coverage ratio: 4.6293695360441935
COGS to revenue (%): 69.1819812019023
SG&A to revenue (%): 12.690842851646655
Free cash flow (dilution-adjusted): -17593139.841688655
Buyback yield (%): 0
Retained earnings: 70875461.7414248
Inventory turnover: 1.6539731900213452
Receivables turnover: 20.89687595681847
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.049330332373012
FCF margin (%): -3.1515125161526956
Rule of 40 score: -3.1515125161526956
Financial ratios for CPAC — annual report dated 2023-12-31
Total revenue: 527047297.2972973
Gross profit: 186338378.37837836
Operating income: 104188918.91891891
Net income: 45648648.64864865
Capital expenditures: 73299459.45945945
Operating cash flow: 111438648.64864865
Depreciation & amortization: 38971621.621621616
Net tangible assets: 305855945.9459459
Owner earnings: 11320810.810810804
Return on net tangible assets (%): 3.701353843489293
Capex to operating income (%): 70.3524522761408
Buffett classification: The Good
Stock price: 4.71
P/E ratio: 8.746898138721136
Shares outstanding: 84773690
Book value: 321623783.7837838
P/B ratio: 1.2414631629619297
Market cap (USD): 399284079.9
Debt to equity: 1.3286927482840452
Current ratio: 1.4393186420419273
Quick ratio: 0.2918167998282536
Effective tax rate (%): 31.25986943852052
Interest coverage ratio: 3.8195824704984793
COGS to revenue (%): 64.64484699306436
SG&A to revenue (%): 14.452110816250658
Free cash flow (dilution-adjusted): 33247567.567567565
Buyback yield (%): 0
Retained earnings: 70809189.18918918
Inventory turnover: 1.5935588832397476
Receivables turnover: 19.824685358762174
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.22299274151607
FCF margin (%): 6.308270194736099
Revenue growth (%): -5.588418611839181
Rule of 40 score: 0.7198515828969176
Financial ratios for CPAC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.27
Shares outstanding: 84773690
Market cap (USD): 446757346.29999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPAC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.23
Shares outstanding: 84773690
Market cap (USD): 443366398.70000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPAC — annual report dated 2024-12-31
Total revenue: 538983923.7057221
Gross profit: 198508446.86648503
Operating income: 106548501.36239782
Net income: 54189373.297002725
Capital expenditures: 16325613.079019073
Operating cash flow: 87504359.67302452
Depreciation & amortization: 43118801.089918256
Net tangible assets: 314394277.9291553
Owner earnings: 80982561.30790192
Return on net tangible assets (%): 25.758280920796622
Capex to operating income (%): 15.322236230701758
Buffett classification: The Great
Stock price: 5.23
P/E ratio: 8.181796018750472
Shares outstanding: 84773690
Book value: 330544414.1689373
P/B ratio: 1.3413217095642727
Market cap (USD): 443366398.70000005
Debt to equity: 1.238655904139649
Current ratio: 1.2964398377647588
Quick ratio: 0.2854125438407428
Effective tax rate (%): 32.854919358378325
Interest coverage ratio: 3.950746132939976
COGS to revenue (%): 63.16987610657049
SG&A to revenue (%): 15.620369541841523
Free cash flow (dilution-adjusted): 65465940.054495916
Buyback yield (%): 0
Retained earnings: 77750681.19891009
Inventory turnover: 1.6144054821917913
Receivables turnover: 15.125757981265531
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.289729421684257
FCF margin (%): 12.146176755030533
Revenue growth (%): 2.2648112360381902
Rule of 40 score: 14.410987991068723
Financial ratios for CPAC — quarterly report dated 2025-03-31
Total revenue: 141407365.4390935
Gross profit: 51942776.20396601
Operating income: 27092634.56090652
Net income: 14921529.745042494
Capital expenditures: 9554957.507082153
Operating cash flow: 16905665.722379602
Depreciation & amortization: 11044759.206798868
Net tangible assets: 342360623.2294618
Owner earnings: 16411331.444759209
Return on net tangible assets (%): 4.793580315969858
Capex to operating income (%): 35.26773110825308
Buffett classification: The Good
Stock price: 5.8
P/E ratio: 8.23788529730602
Shares outstanding: 84773690
Book value: 358562606.2322947
P/B ratio: 1.3712735055296326
Market cap (USD): 491687402
Debt to equity: 0.014374359063493993
Current ratio: 1.3272920068264968
Quick ratio: 0.33753966516402856
Effective tax rate (%): 28.763473580286984
Interest coverage ratio: 4.194237347601088
COGS to revenue (%): 63.267276748509516
SG&A to revenue (%): 17.274344509263415
Free cash flow (dilution-adjusted): 6864022.662889519
Buyback yield (%): 0
Retained earnings: 95755807.3654391
Inventory turnover: 0.42082638196713446
Receivables turnover: 3.3858885135593453
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9412064327254024
FCF margin (%): 4.8540771844348996
Rule of 40 score: 4.8540771844348996
Financial ratios for CPAC — quarterly report dated 2025-06-30
Total revenue: 139110344.8275862
Gross profit: 51633908.04597701
Operating income: 26070689.655172415
Net income: 13741954.022988506
Capital expenditures: 4879310.344827586
Operating cash flow: 14418965.51724138
Depreciation & amortization: 11371264.367816092
Net tangible assets: 361229022.9885057
Owner earnings: 20233908.04597701
Return on net tangible assets (%): 5.601407073711476
Capex to operating income (%): 18.71569340652073
Buffett classification: The Great
Stock price: 5.95
P/E ratio: 17.597423243526734
Shares outstanding: 84773690
Book value: 377427873.56321836
P/B ratio: 1.3364234356568092
Market cap (USD): 504403455.5
Debt to equity: 1.1177959707609508
Current ratio: 1.3388720768905957
Quick ratio: 0.3971985402046931
Effective tax rate (%): 31.32377861389551
Interest coverage ratio: 4.05842093491389
COGS to revenue (%): 62.88276899178689
SG&A to revenue (%): 18.032488886685506
Free cash flow (dilution-adjusted): 7953448.275862069
Buyback yield (%): 0
Retained earnings: 110873563.21839081
Inventory turnover: 0.40626117685996294
Receivables turnover: 3.064473042861755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7294594244630934
FCF margin (%): 5.7173665162857565
Revenue growth (%): -1.6243995525796437
Rule of 40 score: 4.092966963706113